Evaluation of the BRAHMS Kryptor® Thyroglobulin Minirecovery Test in patients with differentiated thyroid carcinoma

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 2, 2013, Pages 449-453

  Giovanella, Luca ^a   Imperiali, Mauro ^a   Verburg, Frederik A ^b   Ceriani, Luca ^c  

^a REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

differentiated thyroid carcinoma; minirecovery; thyroglobulin; thyroglobulin antibodies

Indexed keywords

HETEROPHILE ANTIBODY; THYROGLOBULIN;

ADULT; AGED; ARTICLE; DIFFERENTIATED THYROID CANCER; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; LABORATORY DEVICE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84875479049     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0378     Document Type: Article

References (24)

1. Grebe SK. Diagnosis and management of thyroid carcinoma: focus on serum thyroglobulin. Expert Rev Endocrinol Metab 2009;4:25-43.
2. Giovanella L. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management. Clin Chem Lab Med 2008;46:1067-73.
3. Spencer C. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab 2004;89:3702-4.
4. Clark P, Franklyn J. Can we interpret serum thyroglobulin results? Ann Clin Biochem 2012;49:313-22.
5. Mariotti S, Barbesino G, Caturegli P, MarinóM, Manetti L, Pacini F, et al. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? J Clin Endocrinol Metab 1995;80:468-72.
6. Feldt-Rasmussen U, Rasmussen AK. Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo. J Endocrinol Invest 1985;8:571-6.
7. Giovanella L, Keller F, Ceriani L, Tozzoli R. Heterophile antibodies may falsely increase or decrease thyroglobulin measurements in patients with differentiated thyroid carcinoma. Clin Chem Lab Med 2009;47:952-4.
8. Verburg FA, Waschle K, Reiners C, Giovanella L, Lentjes EG. Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin-antibodies in differentiated thyroid cancer patients. Horm Metab Res 2010;42:736-73.
9. Schaadt B, Feldt-Rasmussen U, Rasmusson B, Toørring H, Foder B, Joørgensen K, et al. Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma. Thyroid 1995;5:165-70.
10. Giovanella L, Ceriani L. Comparison of thyroglobulin antibody interference in first-and second-generation thyroglobulin immunoassays. Clin Chem Lab Med 2011;49:1025-27.
11. Spencer C, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005;90:5566-75.
12. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803.
13. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
14. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid diseases. Thyroid 2003;13:3-126.
15. Krahn J, Dembinski T. Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem 2009;42:416-19.
16. Spencer C, Petrovic I, Fatemi S. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 2011;96:1283-91.
17. Algeciras-Schiminich A, Lasho MA, Ness KM, Cheryk LA, Grebe SK. The Roche Elecsys and Siemens-Centaur thyroglobulin autoantibody assays show comparable clinical performance to the recently unavailable Beckman-Coulter access thyroglobulin autoantibody assay in identifying samples with potentially false-low thyroglobulin measurements due to thyroglobulin autoantibody interference. Thyroid 2011;21:813-4.
18. Giovanella L, Maffioli M, Ceriani L, De Palma D, Spriano G. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma. Clin Chem Lab Med 2009;47:1001-4.
19. Zophel K, Wunderlich G, Liepach U, Koch R, Bredow J, Franke WG. Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of differentiated thyroid carcinoma. Nuklearmedizin 2001;40:155-63.
20. Persoon AC, Links TP, Wilde J, Sluiter WJ, Wolffenbuttel BH, van der Ouweland JM. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma. Clin Chem 2006;52:1196-9.
21. Verburg FA, Grelle I, Giovanella L, Reiners C. The thyroglobulin'mini- recovery'testing on the automated BRAHMS KRYPTOR platform is a valid addition to conventional Tg and recovery testing in thyroid healthy subjects. Horm Metab Res 2012;44:555-7.
22. Giovanella L. Toffalori E, Ceriani L, Caputo M, Verburg FA. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR platform in patients with differentiated thyroid carcinoma. Horm Metab Res 2011;43:728-30.
23. Dimeski G. Interference testing. Clin Biochem Rev 2008;29:S43-S48 .
24. Bolstad N, Warren DJ, Bjerner J, Kravdal G, Schwettemann L, Olsen KH, et al. Heterophilic antibody interference in commercial immunoassays: a screening study using paired native and pre-blocked sera. Clin Chem Lab Med 2011;49:2001-6.